Guide — Endocrine
Hypoglycemia Management
Classification by severity, causes, adrenergic and neuroglycopenic symptoms, Rule of 15, severe hypoglycemia protocols, Somogyi effect vs dawn phenomenon, hypoglycemia unawareness, and patient education.
9 min read · Endocrine
Educational use only. Hypoglycemia treatment protocols vary by institution. Always follow facility-specific protocols and provider orders. Severe hypoglycemia is a medical emergency. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
Classification by Severity
| Level | Glucose | Symptoms | Treatment |
|---|---|---|---|
| Level 1 (Alert value) | < 70 mg/dL | Adrenergic symptoms: tremor, diaphoresis, tachycardia, palpitations, anxiety, hunger — patient is conscious and alert | Rule of 15 (15g fast-acting carbs); recheck in 15 min |
| Level 2 (Clinically significant) | < 54 mg/dL | Neuroglycopenic symptoms add: confusion, difficulty concentrating, behavior change, blurred vision, headache, weakness | Rule of 15 if conscious and able to swallow; IV dextrose if unable to swallow safely |
| Level 3 (Severe) | Any level with severe cognitive impairment | Seizure, loss of consciousness, unresponsiveness — patient requires assistance from another person | D50W IV (preferred if IV access) or glucagon IM/SQ; do NOT give oral glucose to unconscious patient |
Common Causes
| Cause | Mechanism / Clinical Note |
|---|---|
| Insulin excess (most common) | Too much insulin (absolute or relative), wrong type, poor timing relative to meals |
| Sulfonylureas / Meglitinides | Stimulate insulin secretion regardless of glucose level; high hypoglycemia risk especially when meal is delayed or skipped |
| Delayed or missed meal | Insulin on board without adequate glucose substrate |
| Alcohol consumption | Inhibits hepatic gluconeogenesis; mask hypoglycemia symptoms by mimicking intoxication |
| Strenuous exercise | Increases glucose utilization; effect can persist hours after exercise |
| Renal/hepatic failure | Impaired insulin degradation (kidneys) and impaired gluconeogenesis (liver) prolong and worsen hypoglycemia |
| Drug interactions | Beta-blockers mask adrenergic symptoms (tachycardia, tremor) — patient may present directly with neuroglycopenic symptoms |
| Adrenal insufficiency | Cortisol is a counter-regulatory hormone — its absence blunts glucose recovery |
Rule of 15 — Mild to Moderate Hypoglycemia
Step-by-Step Protocol
- Confirm glucose < 70 mg/dL via glucometer
- Administer 15 grams of fast-acting carbohydrates orally
- Wait 15 minutes
- Recheck blood glucose
- If glucose still < 70 mg/dL: repeat 15g carbs and wait 15 min
- If glucose > 70 mg/dL and meal not imminent: give small snack containing protein + complex carb (e.g., peanut butter crackers) to prevent rebound
- Notify provider and document
15g Fast-Acting Carbohydrate Options
Avoid: chocolate, peanut butter, high-fat foods — fat delays glucose absorption and slows treatment response
Severe Hypoglycemia — Emergency Treatment
| Treatment | Route | Dose | Notes |
|---|---|---|---|
| D50W (50% dextrose) | IV (preferred) | 25g (50 mL of D50W) — per order | Fastest onset; requires IV access; give slowly — vesicant, causes vein damage if extravasates; recheck glucose in 15 min |
| Glucagon kit | IM or SQ (when no IV access) | 1 mg (adults); 0.5 mg (children < 20 kg) | Stimulates hepatic glycogenolysis; requires glycogen stores (may be ineffective in malnourished, alcoholics, or prolonged hypoglycemia); onset 10–15 min; causes nausea/vomiting — position patient laterally |
| Nasal glucagon (Baqsimi) | Intranasal | 3 mg (one nasal spray) | Newer formulation; no mixing required; approved for community/outpatient use; same mechanism as IM glucagon |
Critical Safety Points
- NEVER give oral glucose to an unconscious or seizing patient — aspiration risk
- After D50W or glucagon, give follow-up carbohydrates + protein to prevent rebound hypoglycemia
- Notify provider after any severe hypoglycemia — insulin regimen review required
- Document: time detected, glucose value, treatment given, time of recheck, glucose after treatment, patient response, provider notified
Somogyi Effect vs Dawn Phenomenon
| Feature | Somogyi Effect (Rebound Hyperglycemia) | Dawn Phenomenon |
|---|---|---|
| Cause | Nocturnal hypoglycemia (2–3am) triggers counter-regulatory hormones (glucagon, cortisol, epinephrine) → rebound hyperglycemia by morning | Normal physiologic rise in growth hormone and cortisol in early morning (4–8am) → hepatic glucose release and insulin resistance → fasting hyperglycemia |
| 2–3am glucose | Low (hypoglycemic) | Normal or slightly elevated |
| Fasting AM glucose | High (rebound from nocturnal hypo) | High |
| Treatment | REDUCE evening/bedtime insulin dose — increasing insulin worsens nocturnal hypoglycemia | INCREASE basal insulin dose or adjust timing; early AM snack may help in some cases |
| How to differentiate | Check 2–3am glucose: LOW = Somogyi (reduce PM insulin). NORMAL/HIGH = Dawn phenomenon (increase basal or add coverage). | |
Hypoglycemia Unawareness
Definition: Inability to recognize hypoglycemia symptoms until glucose is severely low — patients skip adrenergic warning signs and present directly with neuroglycopenic symptoms (confusion, loss of consciousness).
Cause: Occurs after frequent hypoglycemic episodes — the counter-regulatory hormone response becomes blunted; beta-blockers can mask adrenergic symptoms even in people without unawareness.
Risk factors: Long-standing Type 1 DM, frequent hypoglycemia, autonomic neuropathy, beta-blocker use, elderly patients.
Nursing implications:
- More frequent glucose monitoring (CGM is ideal)
- Higher glucose target thresholds for these patients
- Educate family/caregivers on how to administer glucagon
- Educate patient to check glucose before driving
- Inform provider — insulin regimen adjustment may be warranted
NCLEX Pearls
Treat first, notify second: Glucose < 50 with symptoms = treat immediately (D50W or Rule of 15), then notify provider. Do NOT wait for an order to treat severe symptomatic hypoglycemia — nurses have standing orders for this.
Unconscious patient: IV D50W preferred; if no IV access, glucagon IM or nasal. NEVER oral glucose — aspiration.
Beta-blockers mask hypoglycemia: Patients on beta-blockers may not show tachycardia or tremor — diaphoresis is NOT masked and remains a reliable sign. More frequent monitoring needed.
Somogyi = reduce PM insulin: High morning glucose with low 2–3am glucose = rebound. Do NOT increase insulin — reduce it.
Glucagon requires glycogen stores: Will be ineffective in malnourished, prolonged fasting, alcoholic, or liver failure patients — use D50W instead.
Follow-up snack after treatment: After glucose rises above 70 mg/dL, give protein + complex carb snack if next meal is > 1 hour away — prevents rebound hypoglycemia from treatment.
Related Resources
Standards & sources
Fact-checked Jun 20, 2026This page is written to align with American Diabetes Association (ADA) Standards of Care · American Association of Clinical Endocrinology (AACE). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →